poisar

Stocks · News reference

Summit Therapeutics Stock Climbs Wednesday: What's Happening?

BenzingaHenry Khederian

Shares of Summit Therapeutics moved higher in Wednesday afternoon trading, extending gains from the previous session following a landmark $2.0 billion strategic equity investment from pharmaceutical titan AstraZeneca PLC to accelerate the clinical development of ivonescimab.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading